212 related articles for article (PubMed ID: 38824212)
21. EQ-5D-3L health state utility values in transfusion-dependent thalassemia patients in Malaysia: a cross-sectional assessment.
Shafie AA; Chhabra IK; Wong JHY; Mohammed NS
Health Qual Life Outcomes; 2021 Jan; 19(1):10. PubMed ID: 33413416
[TBL] [Abstract][Full Text] [Related]
22. Health state utility values associated with advanced gastric, oesophageal, or gastro-oesophageal junction adenocarcinoma: a systematic review.
Carter GC; King DT; Hess LM; Mitchell SA; Taipale KL; Kiiskinen U; Rajan N; Novick D; Liepa AM
J Med Econ; 2015; 18(11):954-66. PubMed ID: 26212479
[TBL] [Abstract][Full Text] [Related]
23. A Systematic Review and Meta-Analysis of Health Utility Estimates in Chronic Spontaneous Urticaria.
Yuan Y; Xiao Y; Chen X; Li J; Shen M
Front Med (Lausanne); 2020; 7():543290. PubMed ID: 33425930
[No Abstract] [Full Text] [Related]
24. EQ-5D-5L is More Responsive than EQ-5D-3L to Treatment Benefit of Cataract Surgery.
Gandhi M; Ang M; Teo K; Wong CW; Wei YC; Tan RL; Janssen MF; Luo N
Patient; 2019 Aug; 12(4):383-392. PubMed ID: 30607809
[TBL] [Abstract][Full Text] [Related]
25. Health Utilities for Multiple Sclerosis.
Hawton A; Green C
Value Health; 2016 Jun; 19(4):460-8. PubMed ID: 27325338
[TBL] [Abstract][Full Text] [Related]
26. Catalog of EQ-5D-3L Health-Related Quality-of-Life Scores for 199 Chronic Conditions and Health Risks in Denmark.
Hvidberg MF; Petersen KD; Davidsen M; Witt Udsen F; Frølich A; Ehlers L; Alava MH
MDM Policy Pract; 2023; 8(1):23814683231159023. PubMed ID: 37056295
[TBL] [Abstract][Full Text] [Related]
27. Mapping the PHQ-8 to EQ-5D, HUI3 and SF6D in patients with depression.
Abdin E; Chong SA; Seow E; Tan KB; Subramaniam M
BMC Psychiatry; 2021 Sep; 21(1):451. PubMed ID: 34517871
[TBL] [Abstract][Full Text] [Related]
28. Health state utility values derived from EQ-5D in psoriatic patients: a systematic review and meta-analysis.
Yang Z; Li S; Wang X; Chen G
J Dermatolog Treat; 2022 Mar; 33(2):1029-1036. PubMed ID: 32716651
[TBL] [Abstract][Full Text] [Related]
29. An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility Values.
Mukuria C; Rowen D; Harnan S; Rawdin A; Wong R; Ara R; Brazier J
Appl Health Econ Health Policy; 2019 Jun; 17(3):295-313. PubMed ID: 30945127
[TBL] [Abstract][Full Text] [Related]
30. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D.
Shiroiwa T; Fukuda T; Ikeda S; Igarashi A; Noto S; Saito S; Shimozuma K
Qual Life Res; 2016 Mar; 25(3):707-19. PubMed ID: 26303761
[TBL] [Abstract][Full Text] [Related]
31. Health state utility values (QALY weights) for Huntington's disease: an analysis of data from the European Huntington's Disease Network (EHDN).
Hawton A; Green C; Goodwin E; Harrower T
Eur J Health Econ; 2019 Dec; 20(9):1335-1347. PubMed ID: 31410669
[TBL] [Abstract][Full Text] [Related]
32. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
Cheung PWH; Wong CKH; Cheung JPY
Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
[TBL] [Abstract][Full Text] [Related]
33. Mapping Sri Lankan EQ-5D-3L to EQ-5D-5L Value Sets.
Kularatna S; Chen G; Byrnes J; Scuffham PA
Value Health Reg Issues; 2017 May; 12():20-23. PubMed ID: 28648311
[TBL] [Abstract][Full Text] [Related]
34. Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D.
Cox IA; Campbell J; de Graaff B; Otahal P; Corte TJ; Moodley Y; Hopkins P; Macansh S; Walters EH; Palmer AJ
Qual Life Res; 2023 Feb; 32(2):473-493. PubMed ID: 35927542
[TBL] [Abstract][Full Text] [Related]
35. Health state utility values for children and adolescents with type 1 diabetes: A systematic review and meta-analysis.
Xie S; Li M; Chen X; Guo W; Liu X; Yang K; Wu J
Diabet Med; 2024 Jan; 41(1):e15251. PubMed ID: 37915225
[TBL] [Abstract][Full Text] [Related]
36. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
Wong CKH; Lang BHH; Yu HMS; Lam CLK
Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
[TBL] [Abstract][Full Text] [Related]
37. Measurement properties of the EQ-5D in populations with a mean age of ≥ 75 years: a systematic review.
Gottschalk S; König HH; Nejad M; Dams J
Qual Life Res; 2023 Feb; 32(2):307-329. PubMed ID: 35915354
[TBL] [Abstract][Full Text] [Related]
38. Systematic Review and Meta-Analysis of Health State Utility Values for Osteoarthritis-Related Conditions.
Zhao T; Winzenberg T; de Graaff B; Aitken D; Ahmad H; Palmer AJ
Arthritis Care Res (Hoboken); 2022 Feb; 74(2):291-300. PubMed ID: 33026702
[TBL] [Abstract][Full Text] [Related]
39. Psychometric performance of the CFQ-R-8D compared to the EQ-5D-3L and SF-6D in people with cystic fibrosis.
Mukuria C; Rowen D; Acaster S; McGarry LJ; Lou Y; Sosnay PR; Quittner AL
J Patient Rep Outcomes; 2024 Feb; 8(1):24. PubMed ID: 38416239
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
